These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard. Hardie AD, Kizziah MK, Rissing MS. J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541 [Abstract] [Full Text] [Related]
24. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver. Pauleit D, Textor J, Bachmann R, Conrad R, Flacke S, Layer G, Kreft B, Schild H. Radiology; 2002 Jan; 222(1):73-80. PubMed ID: 11756708 [Abstract] [Full Text] [Related]
25. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images. Kelekis NL, Semelka RC, Worawattanakul S, de Lange EE, Ascher SM, Ahn IO, Reinhold C, Remer EM, Brown JJ, Bis KG, Woosley JT, Mitchell DG. AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051 [Abstract] [Full Text] [Related]
26. Image quality and focal lesion detection on T2-weighted MR imaging of the liver: comparison of two high-resolution free-breathing imaging techniques with two breath-hold imaging techniques. Lee SS, Byun JH, Hong HS, Park SH, Won HJ, Shin YM, Lee MG. J Magn Reson Imaging; 2007 Aug; 26(2):323-30. PubMed ID: 17610287 [Abstract] [Full Text] [Related]
27. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE, Choi JY. Radiology; 2010 May; 255(2):459-66. PubMed ID: 20413759 [Abstract] [Full Text] [Related]
28. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging. Quaia E, Pizzolato R, De Paoli L, Angileri R, Ukmar M, Cova MA. J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278 [Abstract] [Full Text] [Related]
30. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging. Yu JS, Lee JH, Chung JJ, Kim JH, Kim KW. Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015 [Abstract] [Full Text] [Related]
31. MR imaging of the liver: comparison between single-shot echo-planar and half-Fourier rapid acquisition with relaxation enhancement sequences. Yamashita Y, Tang Y, Namimoto T, Mitsuzaki K, Takahashi M. Radiology; 1998 May; 207(2):331-7. PubMed ID: 9577477 [Abstract] [Full Text] [Related]
33. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging. Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Muhi A, Araki T. Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092 [Abstract] [Full Text] [Related]
34. Double-contrast MRI for accurate staging of hepatocellular carcinoma in patients with cirrhosis. Hanna RF, Kased N, Kwan SW, Gamst AC, Santosa AC, Hassanein T, Sirlin CB. AJR Am J Roentgenol; 2008 Jan; 190(1):47-57. PubMed ID: 18094293 [Abstract] [Full Text] [Related]
35. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity. Tanabe M, Ito K, Shimizu A, Fujita T, Onoda H, Yamatogi S, Washida Y, Matsunaga N. Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487 [Abstract] [Full Text] [Related]
36. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K, Hirohashi S, Nishie A, Saito Y, Onaya H, Kuwatsuru R, Morimoto A, Ueda K, Kurauchi M, Breuer J. Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330 [Abstract] [Full Text] [Related]
37. Hepatic lesion detection at MR imaging: a comparative study with four sequences. Blakeborough A, Ward J, Wilson D, Griffiths M, Kajiya Y, Guthrie JA, Robinson PJ. Radiology; 1997 Jun; 203(3):759-65. PubMed ID: 9169701 [Abstract] [Full Text] [Related]
38. Focal liver lesions: breathhold gradient- and spin-echo T2-weighted imaging for detection and characterization. Yoshikawa T, Mitchell DG, Hirota S, Ohno Y, Yoshigi J, Maeda T, Fujii M, Sugimura K. J Magn Reson Imaging; 2006 Apr; 23(4):520-8. PubMed ID: 16523481 [Abstract] [Full Text] [Related]
39. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session]. Heilmaier C, Sutter R, Lutz AM, Seifert B, Willmann JK. Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745 [Abstract] [Full Text] [Related]
40. Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging? Hamm B, Mahfouz AE, Taupitz M, Mitchell DG, Nelson R, Halpern E, Speidel A, Wolf KJ, Saini S. Radiology; 1997 Mar; 202(3):677-82. PubMed ID: 9051015 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]